Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: OXANDRIN

« Back to Dashboard

Summary for Tradename: OXANDRIN

Patents:4
Applicants:1
NDAs:1
Suppliers: see list1

Clinical Trials for: OXANDRIN

Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia
Status: Completed Condition: Fanconi Anemia

Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer
Status: Completed Condition: Unspecified Adult Solid Tumor, Protocol Specific; Weight Changes

Bioavailability Study of Oxandrolone Tablets Under Fasting Conditions
Status: Completed Condition: To Determine the Bioequivalence Under Fasting Conditions

Pilot Study of the Safety and Efficacy of Oxandrolone in the Prevention and Treatment of Malnutrition in Infants
Status: Completed Condition: Malnutrition

Pilot Study of Goal-Directed Iron Supplementation +/- Oxandrolone for Functional Iron Deficiency of Critical Illness
Status: Not yet recruiting Condition: Functional Iron Deficiency; Trauma; Anemia

Oxandrolone to Heal Pressure Ulcers
Status: Terminated Condition: Pressure Ulcer

Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
Status: Completed Condition: Turner's Syndrome

The Use of Anabolic Steroids to Improve Function After Spinal Cord Injury
Status: Completed Condition: Spinal Cord Injury

Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
Status: Completed Condition: Muscular Dystrophies

Assessment of the Treatment of Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
Status: Recruiting Condition: Burns

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Approved Prior to Jan 1, 1982RXNo6,828,313<disabled><disabled>
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Approved Prior to Jan 1, 1982RXNo5,872,147<disabled><disabled>
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Nov 5, 2001RXYes6,828,313<disabled><disabled>
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Approved Prior to Jan 1, 1982RXNo6,576,659<disabled><disabled>
Crealta Pharms Llc
OXANDRIN
oxandrolone
TABLET;ORAL013718Nov 5, 2001RXYes6,090,799<disabled><disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: OXANDRIN

Drugname Dosage Strength RLD Submissiondate
oxandroloneTablets2.5 mg and 10 mgOxandrin6/19/2006
« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc